During the past decade, Providence Cardiology LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Providence Cardiology LLC" are "Contrast Induced Nephropathy (CIN)" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Providence Cardiology LLC" in a lesser frequency.

Most popular intervention types in "Providence Cardiology LLC" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "AVERT" (1 trials), "Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter" (1 trials) and "EverCross Percutaneous Transluminal Balloon Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cardiology LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Providence Cardiology LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Providence Cardiology LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cardiology LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".